Add to ORKGA randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cance
Background: To compare irinotecan with the Nordic 5- fluorouracil (5- FU) and folinic acid (FA) bolu...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(85) / BLDSC - British Librar...
A biweekly regimen of irinotecan 200 mg/m2 on day 1 and levo-leucovorin (LV) 250 mg/m2 plus 5-fluoro...
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in f...
AbstractCombination chemotherapy based on bolus or infusional 5-fluorouracil (5-FU), folinic acid (F...
Irinotecan is active against colorectal cancer in patients whose disease is refractory to fluorourac...
The recent incorporation of irinotecan (CPT-11) for the management of advanced colorectal cancer has...
Introduction This multicenter phase II study determined the efficacy and safety of new daily oral S-...
To demonstrate that adding irinotecan to a standard weekly schedule of high-dose, infusional fluorou...
Background: Irinotecan is a topoisomerase I inhibitor that prolongs survival as second- line therapy...
The combination of irinotecan (CPT-11), oxaliplatin (L-OHP), 5-fluorouracil (5-FU) and folinic acid ...
The value of adjuvant chemotherapy for some patients with stage III colorectal cancer has been estab...
This phase III study compared the safety and efficacy of the following three different irinotecan-co...
The efficacy of combination therapy with irinotecan and capecitabine has been demonstrated for the f...
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line ...
Background: To compare irinotecan with the Nordic 5- fluorouracil (5- FU) and folinic acid (FA) bolu...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(85) / BLDSC - British Librar...
A biweekly regimen of irinotecan 200 mg/m2 on day 1 and levo-leucovorin (LV) 250 mg/m2 plus 5-fluoro...
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in f...
AbstractCombination chemotherapy based on bolus or infusional 5-fluorouracil (5-FU), folinic acid (F...
Irinotecan is active against colorectal cancer in patients whose disease is refractory to fluorourac...
The recent incorporation of irinotecan (CPT-11) for the management of advanced colorectal cancer has...
Introduction This multicenter phase II study determined the efficacy and safety of new daily oral S-...
To demonstrate that adding irinotecan to a standard weekly schedule of high-dose, infusional fluorou...
Background: Irinotecan is a topoisomerase I inhibitor that prolongs survival as second- line therapy...
The combination of irinotecan (CPT-11), oxaliplatin (L-OHP), 5-fluorouracil (5-FU) and folinic acid ...
The value of adjuvant chemotherapy for some patients with stage III colorectal cancer has been estab...
This phase III study compared the safety and efficacy of the following three different irinotecan-co...
The efficacy of combination therapy with irinotecan and capecitabine has been demonstrated for the f...
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line ...
Background: To compare irinotecan with the Nordic 5- fluorouracil (5- FU) and folinic acid (FA) bolu...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(85) / BLDSC - British Librar...
A biweekly regimen of irinotecan 200 mg/m2 on day 1 and levo-leucovorin (LV) 250 mg/m2 plus 5-fluoro...